Target intelligence / Profile preview

Fibronectin 1 (FN1)

Target
FN1
Molecular classification
Extracellular matrix protein, Glycoprotein, Cell adhesion molecule
01

Overview

Fibronectin 1 (FN1) is a high-molecular-weight glycoprotein found in the extracellular matrix and plasma that plays a pivotal role in cell adhesion, migration, and differentiation (UniProt P02751). It serves as a primary ligand for several integrin receptors, particularly integrin alpha-5 beta-1, which mediates cell adhesion and signaling (NCBI Gene 2335). In the immune system, fibronectin is crucial for the migration of leukocytes and the phagocytic activity of macrophages (PubMed PMID: 15549731). The phrase 'fibronectin-mediated adhesion and internalization' often refers to the mechanism by which pathogens or viral vectors enter host cells (PubMed PMID: 11544357). Recombinant fibronectin fragments, such as RetroNectin, are extensively utilized in clinical settings to enhance the transduction efficiency of retroviral and lentiviral vectors into T cells for immunotherapy (Takara Bio). Fibronectin is also involved in wound healing and tissue repair, where it acts as a scaffold for cell migration (PubMed PMID: 23681448). In disease states, elevated fibronectin levels are associated with cancer metastasis and the development of organ fibrosis (PubMed PMID: 25108357). Therapeutic agents targeting the fibronectin-integrin axis, such as volociximab, have been investigated for their anti-angiogenic and anti-tumor properties (ClinicalTrials.gov). Monitoring fibronectin levels, such as oncofetal fibronectin, serves as a biomarker in obstetric and oncological contexts (PubMed PMID: 17210598).

Other names
FibronectinFNCold-insoluble globulinCIGLETSMSFRetroNectin (recombinant fragment)
02

Mechanism of action

Binding to integrin receptors (primarily alpha-5 beta-1) to facilitate cell-matrix adhesion, intracellular signaling, and internalization of ligands or vectors.

03

Biological functions

Cell adhesionCell migrationImmune responseWound healingViral transduction enhancement
04

Disease associations

CancerFibrosisInfectionCardiovascular disease
05

Safety considerations

Promotion of tumor metastasisRisk of tissue fibrosisImmunogenicity of recombinant fragmentsInterference with blood coagulation
06

Interacting drugs

RetroNectin

3 more in the full profile.

07

Biomarkers

Plasma fibronectinOncofetal fibronectin (fFN)

Beyond the preview

Go deeper on Fibronectin 1 (FN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibronectin 1 (FN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call